Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares changing hands.
Liberty Biopharma Stock Up ∞
The stock has a market capitalization of C$21.54 million and a P/E ratio of -12.66. The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 8.19. The stock’s 50 day simple moving average is C$2.00 and its 200 day simple moving average is C$2.00.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
See Also
- Five stocks we like better than Liberty Biopharma
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- The Most Important Warren Buffett Stock for Investors: His Own
- The 3 Most Talked About Investments on WallStreetBets Right Now
- What is a Secondary Public Offering? What Investors Need to Know
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
